Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 200 Total
BPTH - Bio-Path Holdings Inc - Stock Price Chart
TickerBPTH [NASD]
CompanyBio-Path Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap3.36MEPS (ttm)-27.34
P/E-EPS this Y71.22%
Forward P/E-EPS next Y17.36%
PEG-EPS past 5Y34.89%
P/S-EPS next 5Y-
P/B-EPS Q/Q63.17%
Dividend-Sales Q/Q-
Insider Own0.11%Inst Own23.89%
Insider Trans0.00%Inst Trans112.18%
Short Float2.84%EarningsMay 15/b
Analyst Recom1.00Target Price20.00
Avg Volume1.47M52W Range2.08 - 44.80
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
NOVA - Sunnova Energy International Inc - Stock Price Chart
TickerNOVA [NYSE, RUT]
CompanySunnova Energy International Inc
CountryUSA
IndustrySolar
Market Cap520.72MEPS (ttm)-3.37
P/E-EPS this Y32.56%
Forward P/E-EPS next Y-3.14%
PEG-EPS past 5Y-17.44%
P/S0.72EPS next 5Y-14.00%
P/B0.32EPS Q/Q19.20%
Dividend-Sales Q/Q-0.49%
Insider Own18.30%Inst Own96.25%
Insider Trans0.11%Inst Trans7.48%
Short Float39.51%EarningsMay 01/a
Analyst Recom1.68Target Price11.29
Avg Volume10.89M52W Range3.37 - 24.56
Sunnova Energy International, Inc. is an energy services company, which engages in the provision of responsive energy management solutions. The firm also offers solar energy products and services. The company was founded by William Jackson Berger in 2012 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MORGAN MICHAEL CDirectorMay 17 '24Option Exercise0.007,56607,566May 17 06:35 PM
Andrew Anne SDirectorMay 17 '24Option Exercise0.0012,948012,948May 17 06:38 PM
Mohamed AkbarDirectorMay 17 '24Option Exercise0.0011,7980247,937May 17 06:40 PM
Brownell Nora MeadDirectorMay 17 '24Option Exercise0.0012,610035,299May 17 06:39 PM
SHAPER C PARKDirectorMay 17 '24Option Exercise0.007,566019,126May 17 06:41 PM
HGAS - Global Gas Corp - Stock Price Chart
TickerHGAS [NASD]
CompanyGlobal Gas Corp
CountryUSA
IndustrySpecialty Chemicals
Market Cap11.46MEPS (ttm)-0.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-108.78%
Dividend-Sales Q/Q-
Insider Own86.27%Inst Own15.03%
Insider Trans0.00%Inst Trans37.70%
Short Float3.19%Earnings-
Analyst Recom-Target Price-
Avg Volume95.52K52W Range1.05 - 10.66
Global Gas Corporation engages in the development and supply of nascent pure-play hydrogen, carbon and industrial gas. The company was Founded in 1989 and is headquartered in New York, NY.
ZJYL - Jin Medical International Ltd - Stock Price Chart
TickerZJYL [NASD]
CompanyJin Medical International Ltd
CountryChina
IndustryMedical Instruments & Supplies
Market Cap469.65MEPS (ttm)0.23
P/E12.77EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-54.35%
P/S23.70EPS next 5Y-
P/B19.51EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own75.84%Inst Own0.50%
Insider Trans0.00%Inst Trans-
Short Float3.71%Earnings-
Analyst Recom-Target Price-
Avg Volume429.78K52W Range0.24 - 25.49
Feb-08-24 08:40AM Why Is Jin Medical International (ZJYL) Stock Moving Today? (InvestorPlace) +19.44%
Jan-03-24 05:43PM Take Profit: 3 Stocks to Sell That Are Up More Than 500% in 2023 (InvestorPlace) -21.19%
Dec-14-23 08:30AM JIN MEDICAL INTERNATIONAL LTD. Enters into Memorandum of Understanding to Acquire Medical Equipment Sharing Platform (GlobeNewswire) +11.92%
Dec-13-23 08:30AM JIN MEDICAL INTERNATIONAL LTD. Empowers 'Lao Le Hui' Assisted Bathing Project with Portable Nano-thermal Therapy Bath (GlobeNewswire)
Dec-11-23 08:30AM JIN MEDICAL INTERNATIONAL LTD. Secures RMB66 Million in Orders for Innovative Micro-Hyperbaric Oxygen Chamber Equipment (GlobeNewswire) +9.78%
Sep-28-23 04:30PM Jin Medical International Limited Receives NASDAQ Notification Letter Regarding Noncompliance with Continued Listing Rule 5550(a)(3) (PR Newswire) +17.05%
Aug-31-23 10:37AM Jin Medical (NASDAQ: ZJYL) Expands into the Manufacturing Field of lifestyle Beauty Products, Collaborates in Research and Development of Three Beauty and Body Products, Securing Market Orders (PR Newswire) -6.15%
Aug-23-23 04:15PM Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023 (PR Newswire) -18.31%
Aug-17-23 11:36PM JinMed (NASDAQ: ZJYL) Rings the Nasdaq Stock Market Closing Bell on August 17 (PR Newswire) +9.36%
Aug-03-23 05:13AM JinMed's Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology (PR Newswire)
Jin Medical International Ltd. is a holding company, which engages in the design, development, manufacture and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company was founded on January 14, 2020 and is headquartered in Changzhou, China.
LSDI - Lucy Scientific Discovery Inc - Stock Price Chart
TickerLSDI [NASD]
CompanyLucy Scientific Discovery Inc
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap2.57MEPS (ttm)-0.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S128.48EPS next 5Y-
P/B317.39EPS Q/Q-78.19%
Dividend-Sales Q/Q-
Insider Own36.91%Inst Own6.46%
Insider Trans0.00%Inst Trans-
Short Float3.33%Earnings-
Analyst Recom1.00Target Price14.00
Avg Volume1.18M52W Range0.44 - 17.00
Lucy Scientific Discovery, Inc. is an early-stage company, which engages in the manufacture of psychotropics contracts. It focuses on the research, development, and manufacture of psychotropics-based medicines. Its products include raw materials, crude extracts, targeted formulations, white and private label products, and single molecule fractions. The company was founded on February 17, 2017 and is headquartered in Victoria, Canada.
PXLW - Pixelworks Inc - Stock Price Chart
TickerPXLW [NASD]
CompanyPixelworks Inc
CountryUSA
IndustrySemiconductors
Market Cap65.33MEPS (ttm)-0.39
P/E-EPS this Y-10.53%
Forward P/E-EPS next Y56.35%
PEG-EPS past 5Y-33.77%
P/S0.99EPS next 5Y15.00%
P/B6.91EPS Q/Q47.69%
Dividend-Sales Q/Q61.09%
Insider Own10.87%Inst Own24.72%
Insider Trans-1.47%Inst Trans-17.35%
Short Float1.00%EarningsMay 14/a
Analyst Recom1.00Target Price2.50
Avg Volume579.84K52W Range1.01 - 3.08
Pixelworks, Inc. engages in the design and development of integrated circuits used in electronic display devices. It offers consumer electronics and professional display products, video delivery, and streaming solutions for content service providers. Its product categories consist of ImageProcessor integrated circuits (ICs), video co-processor ICs, and transcode ICs. The company was founded by Allen H. Alley, Michael G. West, Kenneth Hunkins, Robert Y. Greenberg and Bradley A. Zenger on January 16, 1997 and is headquartered in Portland, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aman Haley FChief Financial OfficerFeb 16 '24Sale2.6512,56333,330307,973Feb 16 07:03 PM
DEBONIS TODDPresident and CEOFeb 15 '24Sale2.5656,412144,1441,565,065Feb 16 07:01 PM
Aman Haley FChief Financial OfficerFeb 15 '24Sale2.5617,92645,804320,536Feb 16 07:03 PM
Aman Haley FChief Financial OfficerNov 20 '23Sale1.196,7448,035310,462Nov 21 04:48 PM
DEBONIS TODDPresident and CEOAug 18 '23Sale1.3016,44121,4011,533,477Aug 21 04:11 PM
SGHT - Sight Sciences Inc - Stock Price Chart
TickerSGHT [NASD, RUT]
CompanySight Sciences Inc
CountryUSA
IndustryMedical Devices
Market Cap265.72MEPS (ttm)-1.12
P/E-EPS this Y9.12%
Forward P/E-EPS next Y20.28%
PEG-EPS past 5Y-30.17%
P/S3.26EPS next 5Y-
P/B2.42EPS Q/Q6.78%
Dividend-Sales Q/Q2.34%
Insider Own45.08%Inst Own32.07%
Insider Trans-7.94%Inst Trans-3.38%
Short Float5.04%EarningsMay 02/a
Analyst Recom2.67Target Price6.10
Avg Volume161.40K52W Range1.04 - 10.69
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Badawi PaulPresident and CEOApr 03 '24Sale5.0812,57163,8485,750,729Apr 04 07:25 PM
Bauerlein AlisonChief Financial OfficerApr 03 '24Sale5.0810,12351,415426,248Apr 04 07:19 PM
HAYDEN JEREMY B.Chief Legal OfficerApr 03 '24Sale5.084,89324,852168,620Apr 04 07:26 PM
Park Sam BoongChief Operating OfficerApr 03 '24Sale5.083,41417,340261,754Apr 04 07:24 PM
Badawi DavidChief Technology OfficerApr 03 '24Sale5.083,12815,8871,762,776Apr 04 07:24 PM
IEP - Icahn Enterprises L P - Stock Price Chart
TickerIEP [NASD]
CompanyIcahn Enterprises L P
CountryUSA
IndustryOil & Gas Refining & Marketing
Market Cap7.59BEPS (ttm)-1.15
P/E-EPS this Y130.29%
Forward P/E17.53EPS next Y81.13%
PEG-EPS past 5Y-
P/S0.68EPS next 5Y-
P/B2.05EPS Q/Q88.49%
Dividend35.65%Sales Q/Q-23.36%
Insider Own0.44%Inst Own86.40%
Insider Trans0.00%Inst Trans2.85%
Short Float1.28%EarningsMay 08/b
Analyst Recom1.00Target Price25.00
Avg Volume772.72K52W Range15.00 - 36.00
Icahn Enterprises LP operates as holding company. It operates through following eight business segments: Investment, Automotive, Energy, Food Packaging, Metals, Real Estate, Home Fashion, and Pharma. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group LLC. The Energy segment holds ownership in CVR Energy, Inc., which owns majority interests in two separate operating subsidiaries, CVR Refining, LP and CVR Partners, LP. The Food Packaging segment holds ownership in Viskase Cos., Inc., which is engaged in the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Metals segment operates through PSC Metals, Inc., which engages in the business of collecting, processing, and selling ferrous and non-ferrous metals, as well as the processing and distribution of steel pipe and plate products in the Midwest and Southern U.S. The Real Estate segment consists of rental real estate, property development and resort activities. The Home Fashion segment operates through WestPoint Home LLC, which consists of manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operates through Vivus, Inc., a specialized pharmaceutical company. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.
ECX - ECARX Holdings Inc - Stock Price Chart
TickerECX [NASD]
CompanyECARX Holdings Inc
CountryUnited Kingdom
IndustryAuto Parts
Market Cap500.34MEPS (ttm)-0.39
P/E-EPS this Y43.39%
Forward P/E-EPS next Y82.35%
PEG-EPS past 5Y-
P/S0.77EPS next 5Y-
P/B-EPS Q/Q71.33%
Dividend-Sales Q/Q18.83%
Insider Own68.62%Inst Own1.92%
Insider Trans0.00%Inst Trans0.22%
Short Float0.40%EarningsMay 20/b
Analyst Recom1.00Target Price4.82
Avg Volume72.00K52W Range1.48 - 9.34
ECARX Holdings, Inc. engages in the development of mobility technology services. The company was founded on November 12, 2019 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heng Jun HongDirectorSep 27 '23Sale3.242,7438,8870Sep 28 07:02 PM
Heng Jun HongDirectorSep 26 '23Sale3.3247,257157,0782,743Sep 28 07:02 PM
VRDN - Viridian Therapeutics Inc - Stock Price Chart
TickerVRDN [NASD, RUT]
CompanyViridian Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap858.38MEPS (ttm)-4.50
P/E-EPS this Y31.55%
Forward P/E-EPS next Y-5.52%
PEG-EPS past 5Y20.35%
P/S2959.93EPS next 5Y-
P/B2.24EPS Q/Q50.75%
Dividend-Sales Q/Q-26.53%
Insider Own12.82%Inst Own98.39%
Insider Trans6.18%Inst Trans19.03%
Short Float16.74%EarningsMay 08/b
Analyst Recom1.27Target Price36.47
Avg Volume906.09K52W Range10.93 - 28.35
Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fairmount Funds Management LLCDirectorJan 22 '24Buy21.00476,1909,999,9901,839,954Jan 24 06:44 PM
Meisner LaraChief Legal OfficerJun 16 '23Option Exercise23.032762229,998Jun 20 05:23 PM
Meisner LaraChief Legal OfficerJun 16 '23Sale28.352776529,971Jun 20 05:23 PM
Meisner LaraChief Legal OfficerJun 15 '23Option Exercise23.032,26952,25532,240Jun 20 05:23 PM
Meisner LaraChief Legal OfficerJun 15 '23Sale28.022,26963,57729,971Jun 20 05:23 PM
1456789101112131420